サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：自己検査市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年
市場調査レポート
商品コード
1326473

自己検査市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年

Self Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By Sample, By Usage, By Distribution Channel, By Region and Competition

出版日
ページ情報
英文 118 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

自己検査市場- 世界の産業規模、シェア、動向、機会、および予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 118 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の自己検査市場は、予測期間中に目覚ましい成長を遂げると予想されています。

この市場は、これらの製品の利便性とアクセスしやすさ、また、より正確で信頼できるようになった技術の進歩により、ますます人気が高まっています。世界の自己検査市場の成長を促進する主な要因の1つは、これらの製品が提供する利便性とアクセシビリティです。消費者は現在、ヘルスケア専門家を必要とせず、自宅にいながら自分の健康をモニターできます。この利便性は、多忙なスケジュールや移動の問題を抱える人々、あるいは遠隔地に住む人々にとって特に魅力的です。さらに、世界中の人々の間で健康とウェルネスに対する意識が高まっています。消費者は自分の健康についてより積極的に考えるようになり、自分の健康をモニターし改善する方法を模索しています。自己検査製品は、血糖値、コレステロール、血圧などの健康指標を追跡する便利な方法を提供し、消費者が自分の健康について十分な情報を得た上で意思決定するのに役立ちます。このことが、世界の自己検査市場の成長を支えるものと期待されています。

手頃な価格

自己検査製品は、従来のヘルスケア・サービスよりも費用対効果が高いことが多く、これも人気の一因となっています。消費者は、高額な医療検査や医師の診察にお金を払う代わりに、自宅で自分の健康状態をモニターすることでお金を節約することができます。さらに、一部の自己検査製品は保険が適用されるため、消費者の負担はさらに軽減されます。このことは、今後数年間、世界の自己検査市場の需要を支えるものと予想されます。

パーソナライゼーション

世界の自己検査市場は、これらの製品が提供するパーソナライゼーションにより、ここ数年成長してきました。消費者は、糖尿病管理のための血糖値のモニタリングや、不妊治療計画のための排卵の追跡など、個々のニーズに応える幅広い自己検査製品から選択することができます。このようなパーソナライゼーションにより、消費者は自分の健康を管理し、独自の状況に基づいて情報に基づいた決定を下すことができます。さらに、検査結果は検査を受けた本人以外にはわからないため、世界の自己検査市場の成長を支えています。

慢性疾患の有病率の増加

心血管疾患や糖尿病などの慢性疾患の有病率の増加は、2028年までの自己検査市場の成長を支えるものと予想されます。米国には世界第3位の糖尿病人口が存在します。米国では約3,030万人の成人が糖尿病を患っており、これは成人のほぼ10人に1人に相当します。心血管疾患は米国における主要な死因であり、2019年には約659,041人が死亡したと報告されています。心血管疾患の主な要因は糖尿病と高コレステロールです。このため、世界の自己検査市場の血糖値検査とコレステロール検査分野の需要が増加すると予想されます。

遠隔医療の採用拡大

遠隔医療と遠隔患者モニタリングの採用拡大により、在宅検査キットの需要が増加し、世界の自己診断市場の成長を牽引しています。遠隔医療の出現により、特に血糖値を継続的にモニターする必要がある糖尿病患者の場合、患者は在宅診断に切り替えるようになっています。在宅検査キットを使用する糖尿病患者は、自宅で血糖値をチェックし、電話やビデオ通話で医師に相談します。その結果、患者が診療所や病院を訪れる必要性が減少しました。糖尿病人口の増加は、世界の自己検査市場の成長をさらに後押しすると思われます。国際糖尿病連合によると、2021年現在、約5億3,700万人の成人（20～79歳）が糖尿病を患っています。糖尿病患者の総数は、2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予測されています。

遺伝子検査

遺伝学的検査も近年広く行われるようになり、幅広い遺伝的特徴や健康リスクに関する情報が得られる検査が各社から提供されています。このような検査は自宅で行うことができ、消費者は自分の遺伝的体質についてパーソナライズされた情報を得ることができます。この情報は、ライフスタイルを変えたり、医療介入を求めるなど、健康やウェルネスについて十分な情報に基づいた決定を下すために利用できます。

遺伝子検査は、人々が自分の健康や家系をよりよく理解しようとするにつれて、近年ますます人気が高まっています。技術の進歩により、個人がオンラインで遺伝子検査キットを注文し、自宅で快適に検査を行うことが可能になりました。これらの家庭用遺伝子検査製品は、人々が自分の遺伝的体質や潜在的な健康リスクについてより詳しく知るための便利で手頃な方法を提供します。23andMe、AncestryDNA、MyHeritageなど、自宅で使える遺伝子検査キットを提供している会社はたくさんあります。23andMe、AncestryDNA、MyHeritageなどです。これらの会社は、DNAサンプルを提供するための簡単な唾液採取キットを個人に提供しています。サンプルは分析のために研究所に送られ、通常数週間以内に結果が出る。これらの会社が提供する検査は、個人の遺伝的構成に関する豊富な情報を提供することができます。例えば、パーキンソン病、アルツハイマー病、乳がんなど、特定の病気のリスク上昇に関連する特定の遺伝子バリアントを特定することができます。また、個人の先祖や家系に関する情報も提供できるため、家族の歴史をたどることに興味がある人にも役立ちます。このことは、世界の自己検査市場の成長に新たな展望をもたらすと期待されています。

利用可能なカスタマイズ

TechSciリサーチは、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 自己検査の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 地域別
    • 企業別（2022年）
  • 製品マップ
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 販売チャネル別
    • 地域別

第6章 北米の自己検査市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の自己検査市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の自己検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の自己検査市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの自己検査市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 検査タイプ別
    • サンプル別
    • 用途別
    • 流通チャネル別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 世界の自己検査市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Lucira Health, Inc.
    • Essenlix Corporation
    • Abbott Laboratories, Inc.
    • Quidel Corporation
    • ACON Laboratories, Inc.
    • Scanwell Health, Inc.
    • Johnson & Johnson
    • Geratherm Medical AG
    • B. Braun Holding GmbH
    • OraSure Technologies, Inc.
    • bioLytical Laboratories Inc.
    • Bionime Corporation
    • Becton, Dickinson & Company
    • PRIMA Lab SA
    • F. Hoffmann-La Roche AG

第16章 戦略的提言

目次
Product Code: 14871

Global Self Testing Market is expected to grow at an impressive rate during the forecast period. This market has become increasingly popular due to the convenience and accessibility of these products, as well as advances in technology that have made them more accurate and reliable. One of the primary factors driving the growth of the global self-testing market is the convenience and accessibility that these products offer. Consumers can now monitor their health from the comfort of their own homes without the need for a healthcare professional. This convenience is particularly attractive for those with busy schedules, mobility issues, or who live in remote areas. Additionally, the increasing awareness of health and wellness among the population worldwide. Consumers are becoming more proactive about their health and are seeking out ways to monitor and improve their well-being. Self-testing products provide a convenient way to track health indicators such as blood sugar, cholesterol, and blood pressure, which can help consumers make informed decisions about their health. This, in turn, is expected to support the growth of global self-testing market.

Affordability

Self-testing products are often more cost-effective than traditional healthcare services, which has also contributed to their popularity. Consumers can save money by monitoring their health at home instead of paying for expensive medical tests or doctor's visits. Additionally, some self-testing products are covered by insurance, which further reduces costs for consumers. This, in turn, is expected to support the demand for global self-testing market in the coming years.

Personalization

Global self-testing market has grown over the last few years due to the personalization that these products offer. Consumers can choose from a wide range of self-testing products that cater to their individual needs, such as monitoring blood sugar levels for diabetes management or tracking ovulation for fertility planning. This personalization allows consumers to take control of their health and make informed decisions based on their unique circumstances. Additionally, the test results are also not known to anyone else except the one opting for the test, thereby supporting the growth of global self-testing market.

The self-testing kits are highly useful in fertility testing. Home testing kits can provide information on ovulation and fertility status, enabling women to plan their families and make informed decisions about their reproductive health. Fertility testing has traditionally been performed in a clinical setting, but new products have made it possible for women to test their fertility at home. This, in turn, is expected to drive the growth of global self-testing market.

Growing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as cardiovascular diseases and diabetes is expected to support the self-testing market growth through 2028. The United States is home to the world's third-largest diabetic population. Around 30.3 million adults in the United States are suffering from diabetes which is almost 1 in 10 adults. Cardiovascular diseases are the leading cause of death in the United States, with around 659,041 reported deaths in 2019. The major factors contributing to cardiovascular diseases are diabetes and high cholesterol. This, in turn, is expected to increase the demand for blood glucose testing and cholesterol testing segment of global self-testing market.

Growing Adoption of Telemedicine

The growing adoption of telemedicine and remote patient monitoring increased the demand for at-home testing kits, thereby driving the growth of global self-diagnostics market. The advent of telemedicine made patients switch to at-home diagnostics, especially in the case of patients suffering from diabetes who continuously need to monitor their blood glucose levels. Diabetic patients using at-home testing kits check their blood glucose levels at home and then consult their doctor over the phone or video call. This, in turn, has reduced the need for patients to visit clinics and hospitals. The growing diabetic population will further support the growth of global self-testing market. According to International Diabetes Federation, as of 2021, Approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Genetic Testing

Genetic testing has also become more widely available in recent years, with companies offering tests that can provide information on a wide range of genetic traits and health risks. These tests can be performed at home and provide consumers with personalized information on their genetic makeup. This information can be used to make informed decisions about their health and wellness, such as making lifestyle changes or seeking out medical interventions.

Genetic testing has become increasingly popular in recent years as people seek to better understand their health and ancestry. Advances in technology have made it possible for individuals to order genetic testing kits online and perform the tests in the comfort of their own homes. These at-home genetic testing products provide people with a convenient and affordable way to learn more about their genetic makeup and potential health risks. There are many different companies that offer genetic testing kits for use at home, including 23andMe, AncestryDNA, and MyHeritage. These companies provide individuals with a simple saliva collection kit that they can use to provide a DNA sample. The samples are then sent to a laboratory for analysis, and the results are usually available within a few weeks. The tests offered by these companies can provide a wealth of information about an individual's genetic makeup. For example, they can identify specific genetic variants that are associated with an increased risk of certain diseases, such as Parkinson's disease, Alzheimer's disease, and breast cancer. They can also provide information about an individual's ancestry and genealogy, which can be helpful for those interested in tracing their family history. This, in turn, is expected to create new prospects for the growth of global self-testing market.

Market Segmentation

Global Self Testing Market can be segmented by test type, sample, usage, distribution channel, and region. Based on test type, the global self-testing market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, and others. By sample, the global self-testing market can be categorized into blood, urine, and saliva. By usage, the global self-testing market can be split into disposable and reusable. In terms of distribution channels, the global self-testing market can be segmented into retail stores/retail pharmacies, hospital pharmacies, hypermarkets/supermarket, and e-commerce channels/online pharmacies. Regionally, the global self testing market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Lucira Health, Inc., Essenlix Corporation, Abbott Laboratories, Inc., Quidel Corporation, ACON Laboratories, Inc., Scanwell Health, Inc., Johnson & Johnson, Geratherm Medical AG, B. Braun Holding GmbH, OraSure Technologies, Inc., bioLytical Laboratories Inc., Bionime Corporation, Becton, Dickinson & Company, PRIMA Lab SA, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the global Self Testing market.

Recent Developments

  • Premom launched its ovulation prediction kit in 2021, which allows women to track their fertility at home. The kit includes ovulation test strips and a smartphone app that analyzes the results to provide personalized insights into ovulation patterns and fertility status. The Premom ovulation prediction kit has been praised for its accuracy and ease of use.
  • Cue Health launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a compact device that connects to a smartphone to provide results in just 20 minutes. The Cue Health COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • Ellume, Inc. launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a small analyzer device that provides results in just 15 minutes. The Ellume COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • In 2019, 23andMe, Inc. launched its Health + Ancestry service, which provides consumers with information on their genetic traits and health risks. The service includes more than 125 reports on health conditions, such as breast cancer and heart disease, as well as carrier status for inherited conditions.
  • Abbott Laboratories, Inc. launched the Libre 2 continuous glucose monitoring (CGM) system in 2019. The device is worn on the back of the upper arm and provides real-time glucose readings and alerts for high or low blood sugar levels. The Libre 2 also has Bluetooth connectivity, allowing users to share their glucose data with healthcare providers and caregivers.

Report Scope:

In this report, Global Self Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Self Testing Market, By Test Type:

  • Blood Glucose Testing
  • Pregnancy & Fertility Testing
  • Cholesterol Testing
  • Urine Testing
  • COVID-19 Testing
  • Others

Self Testing Market, By Sample:

  • Blood
  • Urine
  • Saliva

Self-Testing Market, By Usage:

  • Disposable
  • Reusable

Self-Testing Market, By Distribution Channel:

  • Retail Stores/Retail Pharmacies
  • Hospital Pharmacies
  • Hypermarket/Supermarket
  • E-Commerce Channels/Online Pharmacies

Self-Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Self Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Self Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
    • 5.2.2. By Sample (Blood, Urine, Saliva)
    • 5.2.3. By Usage (Disposable v/s Reusable)
    • 5.2.4. By Distribution Channel (Retail Stores/Retail Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Usage
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Self Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Usage
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Self Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Usage
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Self Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Usage
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Self Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Usage
        • 6.3.3.2.4. By Distribution Channel

7. Europe Self Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Usage
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Self Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Usage
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Self Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Usage
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Self Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Usage
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Self Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Usage
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Self Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Usage
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Self Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Usage
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Self Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Usage
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Self Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Usage
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Self Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Usage
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Self Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Usage
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Self Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Usage
        • 8.3.5.2.4. By Distribution Channel

9. South America Self Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Usage
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Self Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Usage
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Self Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Usage
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Self Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Usage
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Self Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Usage
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Self Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Usage
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Self Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Usage
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Self Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Usage
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Self Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Lucira Health, Inc.
    • 15.5.2. Essenlix Corporation
    • 15.5.3. Abbott Laboratories, Inc.
    • 15.5.4. Quidel Corporation
    • 15.5.5. ACON Laboratories, Inc.
    • 15.5.6. Scanwell Health, Inc.
    • 15.5.7. Johnson & Johnson
    • 15.5.8. Geratherm Medical AG
    • 15.5.9. B. Braun Holding GmbH
    • 15.5.10. OraSure Technologies, Inc.
    • 15.5.11. bioLytical Laboratories Inc.
    • 15.5.12. Bionime Corporation
    • 15.5.13. Becton, Dickinson & Company
    • 15.5.14. PRIMA Lab SA
    • 15.5.15. F. Hoffmann-La Roche AG

16. Strategic Recommendations